Bausch Health Companies Inc (BHC)
NYSE: BHC · Pharmaceutical Preparations · Quebec, QC · filing with the SEC since 1996
Grade5.3
◀ Past 5.2● Present 5.9▶ Future 4.7
Who owns Bausch Health Companies Inc
As filed with the SECHolders of 5% or more
3
Paulson & Co. Inc. holds 19.1% of Common Shares, no par value, as its SCHEDULE 13D/A filed Aug 14, 2025 says.
Directors and officers
14
report now, of 58 people on the record since 2010. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Paulson & Co. Inc.
SCHEDULE 13D/A · filed Aug 14, 2025 · Common Shares, no par value · 8.9% in Jun 17, 2025
Alex Meruelo
SCHEDULE 13D · filed Apr 7, 2025 · Common shares, no par value
Steven A. Tananbaum
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Shares, no par value
Nomura Holdings, Inc
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Shares, No Par Value · reported falling below 5%, from 6.3% in May 15, 2025
Icahn Partners Master Fund LP
SCHEDULE 13D/A · filed Aug 15, 2025 · Common Stock, no par value · reported falling below 5%, from 9.4% in May 21, 2025
What BHC reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Bausch + Lomb
An entity · legal entity · owns, named in the 10-K filed Feb 19, 2026
Trukera Medical
A company bought · acquisition · Jul 2024 · owns, named in the 10-K filed Feb 19, 2026
XIIDRA® and Certain Other Ophthalmology Assets Acquisition
A company bought · acquisition · Sep 2023 · owns, named in the 10-K filed Feb 19, 2026
AcuFocus, Inc. Acquisition
A company bought · acquisition · Jan 2023 · owns, named in the 10-K filed Feb 19, 2026
Elios Vision
A company bought · acquisition · owns, named in the 10-K filed Feb 19, 2026
Harmac Medical products, Inc.
A company bought · acquisition · owns, named in the 10-K filed Feb 19, 2026
Shibo Zhenmei
A company bought · acquisition · owns, named in the 10-K filed Feb 19, 2026
156 subsidiaries in 51 countries, from the list filed with the 10-K filed Feb 19, 2026.
Insider tradesForm 4
5sales
0purchases
5sales on a scheduled plan
3people selling
$500,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 2, 2025 to Oct 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 55 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Lenar Aimee J. | President, US Pharma | 1 | $300,000 | 1 | 0 | $0 |
| Carson Seana | EVP, General Counsel | 3 | $100,000 | 3 | 0 | $0 |
| Lee Frank D. | director | 1 | $100,000 | 1 | 0 | $0 |
| Paulson & Co. Inc. | 10% owner | 0 | $0 | 0 | 1 | $15.6M |